TipRanks
Akebia Therapeutics (DE:AX9)
FRANKFURT:AX9
Germany Market
AX9
Akebia Therapeutics
RESEARCH TOOLSreports

Akebia Therapeutics (AX9) Balance Sheet

2 Followers

Akebia Therapeutics Balance Sheet

Akebia Therapeutics's total assets for Q2 2026 were $349.66M, a decrease of -3.55% from the previous quarter. DE:AX9 total liabilities were $324.64M for the fiscal quarter, a -3.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 376.56M$ 220.67M$ 241.70M$ 356.05M$ 529.35M
Total Liabilities
$ 343.95M$ 269.86M$ 272.29M$ 350.82M$ 455.34M
Total Equity Gross Minority
$ 32.61M$ -49.19M$ -30.58M$ 5.23M$ 74.01M
Other Metrics
Currency in USD

Akebia Therapeutics Debt to Assets